Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
5,206.29
4,770.10
4,742.99
3,947.09
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
5,206.29
4,770.10
4,742.99
3,947.09
Raw Material Cost
2,840.25
2,888.80
2,288.81
1,907.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.07
22.87
32.47
38.94
Selling and Distribution Expenses
1,206.07
1,043.87
1,025.69
934.97
Other Expenses
13.88
21.77
12.85
9.57
Total Expenditure (Excl Depreciation)
4,215.15
4,173.27
3,475.50
2,977.51
Operating Profit (PBDIT) excl Other Income
991.1
596.8
1267.5
969.5999999999999
Other Income
105.41
61.65
9.31
-11.76
Operating Profit (PBDIT)
1,457.52
958.10
1,444.39
1,136.88
Interest
30.07
22.87
32.47
38.94
Exceptional Items
-51.17
0.00
0.00
3.19
Gross Profit (PBDT)
2,366.04
1,881.30
2,454.18
2,039.20
Depreciation
360.97
299.63
167.59
179.06
Profit Before Tax
1,015.30
635.60
1,244.34
922.06
Tax
220.54
250.62
414.55
334.39
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
794.76
384.98
829.79
587.67
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
794.76
384.98
829.79
587.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
794.76
384.98
829.79
587.67
Equity Capital
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
Reserves
5,781.82
3,342.39
3,017.83
2,216.89
Earnings per share (EPS)
157.56
76.77
165.46
117.18
Diluted Earnings per share
157.56
76.77
165.46
117.18
Operating Profit Margin (Excl OI)
19.04%
12.51%
26.72%
24.56%
Gross Profit Margin
26.43%
19.61%
29.77%
27.9%
PAT Margin
15.27%
8.07%
17.5%
14.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 9.14% vs 0.57% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 106.44% vs -53.60% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 50.82% vs -37.53% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 31.44% vs -29.54% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Kohjin Bio Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
5,206.29
0
5,206.29
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,206.29
0
5,206.29
Raw Material Cost
2,840.25
0
2,840.25
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
30.07
0
30.07
Selling and Distribution Expenses
1,206.07
0
1,206.07
Other Expenses
13.88
0.00
13.88
Total Expenditure (Excl Depreciation)
4,215.15
0
4,215.15
Operating Profit (PBDIT) excl Other Income
991.14
0.00
991.14
Other Income
105.41
0
105.41
Operating Profit (PBDIT)
1,457.52
0
1,457.52
Interest
30.07
0
30.07
Exceptional Items
-51.17
0
-51.17
Gross Profit (PBDT)
2,366.04
0
2,366.04
Depreciation
360.97
0
360.97
Profit Before Tax
1,015.30
0
1,015.30
Tax
220.54
0
220.54
Provisions and contingencies
0
0
0.00
Profit After Tax
794.76
0
794.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
794.76
0
794.76
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
794.76
0
794.76
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
5,781.82
0
5,781.82
Earnings per share (EPS)
157.56
0
157.56
Diluted Earnings per share
157.56
0
157.56
Operating Profit Margin (Excl OI)
19.04%
0%
0.00
19.04%
Gross Profit Margin
26.43%
0%
0.00
26.43%
PAT Margin
15.27%
0%
0.00
15.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 520.63 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 9.14% vs 0.57% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 79.48 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 106.44% vs -53.60% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 135.21 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 50.82% vs -37.53% in Mar 2024
Annual - Interest
Interest 3.01 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 31.44% vs -29.54% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.04%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






